Sequential dual-energy CT for longitudinal assessment of pathologic response to neoadjuvant immuno-chemotherapy in locally advanced gastric cancer

被引:0
作者
Lin, Xiaoxiao [1 ,2 ]
Xu, Shuning [2 ,3 ]
Wang, Yi [2 ,4 ]
Ma, Fei [2 ,5 ]
Qu, Jinrong [1 ,2 ]
Wu, Yue [1 ,2 ]
Li, Jing [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiol, Zhengzhou, Peoples R China
[2] Henan Canc Hosp, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Affiliated Canc Hosp, Dept Gastrointestinal Oncol, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Affiliated Canc Hosp, Dept Pathol, Zhengzhou, Peoples R China
[5] Zhengzhou Univ, Affiliated Canc Hosp, Dept Gastrointestinal Surg, Zhengzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Tomography (X-ray computed); Stomach neoplasms; Neoadjuvant therapy; IODINE CONCENTRATION; COMPUTED-TOMOGRAPHY; CHEMOTHERAPY;
D O I
10.1007/s00330-025-11601-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives To longitudinally evaluate pathologic response outcomes after neoadjuvant immuno-chemotherapy (NICT) for patients with locally advanced gastric cancer (LAGC) using pre- and post-treatment dual-energy CT (DECT). Materials and methods Between Jan 2021 and Dec 2023, 115 patients who underwent NICT plus gastrectomy and triple-phase enhanced DECT scans before and after NICT were retrospectively enrolled. Pathologic tumor regression grade (TRG) was the reference standard, patients were labelled as responders (TRG = 0 + 1) and non-responders (TRG = 2 + 3) accordingly. A two-dimensional free-hand region of interest method was adopted to obtain the iodine concentration (IC) values. Pre- and post-NICT IC and normalized IC (nIC) were measured at arterial/venous/delay phase (AP/VP/DP), respectively; their changes [Delta IC (%)] defined as (IC_post-IC_pre)& frasl;IC_pre x 100% were calculated. Pre- and post-NICT imaging parameters and their changes were compared between different response groups. Non-responders' associated parameters were selected using multivariable logistic regression analysis. Their performances were analyzed by the area under the receiver operating characteristic curve (AUC). Their associations with patient survival were explored by using Kaplan-Meier survival analysis. Results ICDP-pre, Delta ICAP, thickness-post with cut-off value of > 2.306 mg/mL, <= 26.70%, > 18.5 mm, respectively, indicates non-responders with equivalent AUC being 0.616 (95% CI: 0.521-0.705), 0.625 (95% CI: 0.529-0.713), and 0.660 (95% CI: 0.565-0.745). Their combination demonstrated an improved AUC of 0.774 (95% CI: 0.686-0.846) and was associated with patient disease-free survival (DFS) with a hazard ratio being 2.239 (95% CI: 1.004-4.991) (p = 0.026). Conclusion Pre- and post-NICT DECT-based quantifications are useful for longitudinal assessment of pathologic response outcomes after NICT in LAGC. ICDP-pre, Delta ICAP, and thickness-post are equally useful, their combination demonstrated incremental benefit.
引用
收藏
页数:13
相关论文
共 27 条
  • [1] Gastric Cancer, Version 2.2022
    Ajani, Jaffer A.
    D'Amico, Thomas A.
    Bentrem, David J.
    Chao, Joseph
    Cooke, David
    Corvera, Carlos
    Das, Prajnan
    Enzinger, Peter C.
    Enzler, Thomas
    Fanta, Paul
    Farjah, Farhood
    Gerdes, Hans
    Gibson, Michael K.
    Hochwald, Steven
    Hofstetter, Wayne L.
    Ilson, David H.
    Keswani, Rajesh N.
    Kim, Sunnie
    Kleinberg, Lawrence R.
    Klempner, Samuel J.
    Lacy, Jill
    Ly, Quan P.
    Matkowskyj, Kristina A.
    McNamara, Michael
    Mulcahy, Mary F.
    Outlaw, Darryl
    Park, Haeseong
    Perry, Kyle A.
    Pimiento, Jose
    Poultsides, George A.
    Reznik, Scott
    Roses, Robert E.
    Strong, Vivian E.
    Su, Stacey
    Wang, Hanlin L.
    Wiesner, Georgia
    Willett, Christopher G.
    Yakoub, Danny
    Yoon, Harry
    McMillian, Nicole
    Pluchino, Lenora A.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02): : 167 - 192
  • [2] The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging
    Amin, Mahul B.
    Greene, Frederick L.
    Edge, Stephen B.
    Compton, Carolyn C.
    Gershenwald, Jeffrey E.
    Brookland, Robert K.
    Meyer, Laura
    Gress, Donna M.
    Byrd, David R.
    Winchester, David P.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) : 93 - 99
  • [3] Gastric cancer: Preoperative local staging with 3D multi-detector row CT - Correlation with surgical and histopathologic results
    Chen, Chiao-Yun
    Hsu, Jui-Sheng
    Wu, Deng-Chyang
    Kang, Wan-Yi
    Hsieh, Jan-Sing
    Jaw, Twei-Shiun
    Wu, Ming-Tsang
    Liu, Gin-Chung
    [J]. RADIOLOGY, 2007, 242 (02) : 472 - 482
  • [4] Spectral computed tomography in advanced gastric cancer: Can iodine concentration non-invasively assess angiogenesis?
    Chen, Xiao-Hua
    Ren, Ke
    Liang, Pan
    Chai, Ya-Ru
    Chen, Kui-Sheng
    Gao, Jian-Bo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (09) : 1666 - 1675
  • [5] College of American Pathologists, 2020, Protocol for the examination of specimens from patients with carcinoma of the stomach (version: stomach 4.1.0.0) EB/OL
  • [6] Value of spectral CT parameters in predicting the efficacy of neoadjuvant chemotherapy for gastric cancer
    Deng, J.
    Zhang, W.
    Xu, M.
    Liu, X.
    Ren, T.
    Li, S.
    Sun, Q.
    Xue, C.
    Zhou, J.
    [J]. CLINICAL RADIOLOGY, 2024, 79 (01) : 51 - 59
  • [7] Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer
    Elsholtz, Fabian H. J.
    Asbach, Patrick
    Haas, Matthias
    Becker, Minerva
    Beets-Tan, Regina G. H.
    Thoeny, Harriet C.
    Padhani, Anwar R.
    Hamm, Bernd
    [J]. EUROPEAN RADIOLOGY, 2021, 31 (08) : 6116 - 6124
  • [8] The additive value of restaging-CT during neoadjuvant chemotherapy for gastric cancer
    Gertsen, E. C.
    de Jongh, C.
    Brenkman, H. J. F.
    Mertens, A. C.
    Broeders, I. A. M. J.
    Los, M.
    Boerma, D.
    Huinink, D. ten Bokkel
    van Leeuwen, L.
    Wessels, F. J.
    van Hillegersberg, R.
    Ruurda, J. P.
    [J]. EJSO, 2020, 46 (07): : 1247 - 1253
  • [9] Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: the role of PET/computed tomography
    Guc, Zeynep Gulsum
    Turgut, Bulent
    Avci, Arzu
    Cengiz, Fevzi
    Eren Kalender, Mehmet
    Alacacioglu, Ahmet
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (05) : 560 - 567
  • [10] Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide
    Huang, Mao-tao
    Chen, Zhi-xin
    Wei, Bing
    Zhang, Bo
    Wang, Chun-hui
    Huang, Ming-hui
    Liu, Rui
    Tang, Cheng-wei
    [J]. ACTA PHARMACOLOGICA SINICA, 2007, 28 (11) : 1842 - 1850